GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

GE Healthcare to fully acquire Nihon Medi-Physics from Sumitomo Chemical, enhancing its radiopharmaceutical and molecular ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

The Chicago-based medical device and technology giant plans to purchase the remaining 50% stake in Nihon Medi-Physics.

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...

GE HealthCare Technologies Inc. (GEHC) announced its agreement to acquire the remaining 50% stake in Nihon Medi-Physics Co., Ltd or ...

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE Healthcare will acquire Nihon Medi-Physics (NMP), a Tokyo-based radiopharmaceutical firm, by buying the remaining 50% stake from parent Sumitomo Chemical, the companies said on Monday.